Cytomegalovirus and human cancer.
D000230:Adenocarcinoma / Q000382:microbiology; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D002277:Carcinoma / Q000382:microbiology; D002278:Carcinoma in Situ / Q000382:microbiology; D002472:Cell Transformation, Viral; D003043:Cocarcinogenesis; D003110:Colonic Neoplasms / Q000382:microbiology; D003587:Cytomegalovirus / Q000276:immunology / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000382:microbiology*; D011471:Prostatic Neoplasms / Q000382:microbiology; D012514:Sarcoma, Kaposi / Q000382:microbiology; D002583:Uterine Cervical Neoplasms / Q000382:microbiology
D000914:Antibodies, Viral; D000956:Antigens, Viral